Trump is taking credit for lower list prices. But a Biden-era law did a lot of the heavy lifting

List prices for brand-name drugs have declined significantly in 2026. But the reasons behind it may have more to do with a Biden-era law than any of the Trump administration's recent initiatives, experts told Endpoints ...